Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Hawkens Gingerbread is a bakery that makes gingerbread products that are diverse, rich in heritage, delicious, and high in quality. It has spent three years in a start-up phase and now targets a three-year phase of stage one growth. Currently, its facility can bake up to 80,000 units of gingerbread each month. Since 2017, it is consistently producing a 65% average gross profit margin across its B2C and B2B markets. This company has been growing for three years, and in the financial year 2019, its revenue grew 108% to £43k (£25k profit). Its online sales are displaying a strong flow in the upwards direction. Fund raised will enable it to get in front of a much wider audience and bring the necessary skills into the business.
days to go:
Expired
investment:
£67,110
The Brook is a plant-based food business that has been making plant-based eating accessible and enjoyable for a flexitarian, environmentally-conscious generation. The company has raised over £400,000 to date and, has launched an eCommerce platform that allows customers to avail ‘build-a-box’ subscriptions as well as single purchases. The company saw its online orders increasing by nine times during the COVID-19 lockdown. It was shortlisted at the Future Food Awards 2019, Great British Food Awards 2019, and World Food Innovation Awards 2019, to name a few. It has also secured listings with retail partners such as Co-op, Dobbie’s, and Fenwick. The company has appeared in publications like the Independent, Metro and The Times. The Brook will use 40% of the investment to hire staff, 40% to promote marketing, and 20% to accelerate web development.
days to go:
Expired
investment:
£359,830
Integumen is a personal health company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes.
days to go:
Expired
investment:
£2,160,000
Doctaly is the brand new healthcare platform providing the quickest way to find and book an affordable, face-to-face, same day GP appointment. Choose from their trusted private doctors, at a convenient time and location from just £39.99.
days to go:
Expired
investment:
£807,580
The Wine List (WL) gives confidence to wine lovers through a home wine course. The company argues that 20% of the UK's wine drinkers fall into a cohort that is actively engaged, spend at the higher end of the market, and frequently drink from a variety of sources. But less than 20,000 people don't have the requisite knowledge about different wine styles and tastes. WL aims to change this scenario by offering a home wine course to customers where alongside their wine lessons, they also get two bottles of wine to practice their skills on. The company has shipped 20,000+ bottles of wine and witnessed revenues of £298,000 in April-October 2020. WL is also building a digital content platform that will offer best in class video lessons, with learning quizzes to reinforce knowledge. The company has featured in Metro, Evening Standard, and Courier. It will use the investment to increase content production, wine delivery and scale into 2021.
days to go:
Expired
investment:
£505,494
Market Porter is a food-tech platform connecting independant food producers, such as butchers and farm shops, with the consumers. The company are the only food-tech platform which work on a national scale instead of just locally. They source out the best small scale producers with top quality and taste, all delivered straight to your door.
days to go:
Expired
investment:
£885,000
